The history of Viagra and its parent , copyright, presents a fascinating picture for cautious investors. While the iconic drug initially fueled enormous earnings, its exclusivity has lapsed , leading to rival alternatives flooding the arena. This decline in cost presents a substantial obstacle for copyright and any company considering a heavy posit